Reader-supported. We may earn a commission when you use our partner links. How we’re funded

Our take

Worth comparing if format choice matters to you. Strut makes its two advertised prices easy to compare, but the $99 lozenge and $119 injection are different formulations—not interchangeable ways to buy the same clinical result.

From $119/monthInjection, advertised monthly price
Injection + oral lozengeFormat offered
Prescription requiredSubject to clinical evaluation

What stands out

  • Separate injection and lozenge prices published
  • Physician consultations and shipping included
  • Follow-up care and provider messaging advertised

What to weigh

  • Advertised pricing uses auto-refill
  • Final pricing is determined after consultation
  • A lozenge should not be assumed equivalent to an injection

What Strut Health offers

Strut Health offers compounded sermorelin as an injection and a sublingual lozenge. Its pricing section lists $119 for a monthly injection vial and $99 for a 30-day oral supply. The page describes the offering as auto-refill, with final pricing determined after consultation.

The choice of format is the most useful distinction. You can discuss a needle-free option with the clinician rather than assuming injections are the only advertised route. But convenience and clinical effectiveness are separate questions.

My view: Strut provides a clearer comparison of its two advertised formats than a single blended starting price would. I would still confirm the exact formulation, dose, final recurring cost, and pharmacy before deciding.

Price, inclusions, and recurring charges

Strut says physician consultations and free shipping are included in the advertised price. The page also advertises free follow-up care and messaging access to the provider.

The monthly prices appear within an auto-refill offering. Before you start, ask when your card will be charged, when a refill begins processing, and how far in advance you must cancel. “Cancel anytime” does not, by itself, tell you whether a prescription already processed is refundable.

The $99 oral supply costs $20 less than the advertised injection at Strut. This is a price comparison between different formulations, not a cost comparison between equivalent clinical results.

Injection or lozenge?

Strut describes the oral option as a sublingual lozenge and lists a 30-day supply. Its injection is administered under the skin. The website describes different administration routines, but your own prescription and pharmacy instructions should determine how you use a dispensed medication.

Ask the clinician for evidence relevant to the chosen route. An ingredient shared by two preparations is not enough to establish equal absorption or outcomes. Do not convert doses between formats yourself.

For travel or day-to-day convenience, clarify storage and handling before ordering. The right question is not simply which format is easier, but which—if either—is appropriate for the clinical goal.

The care process

The published process begins with a health questionnaire, followed by physician review and a treatment plan if appropriate. Medication is then shipped through the provider’s fulfillment process. Approval is not guaranteed.

Confirm that the clinician can treat you in your state and ask which pharmacy will dispense the prescription. Provider messaging and free follow-ups are useful advertised features; how they work for your situation should be clear before you commit.

Safety and the limits of this review

Strut discloses that compounded medications are not FDA-approved and that the FDA has not evaluated them for safety, effectiveness, or quality. Its safety information is a useful starting point for discussion with a clinician, not a substitute for your own evaluation.

Strut’s page advertises possible benefits for sleep, recovery, and vitality. This review does not verify those outcomes or rank Strut by medical effectiveness. Our evidence guide explains why a mechanism is not the same as a demonstrated benefit.

We have not used Strut as a patient, ordered or tested its medication, or inspected its dispensing pharmacies. This is a research-based assessment of the published offer.

Regulatory context

FDA issued Strut Health a warning letter in February 2026 about misleading marketing of compounded semaglutide and tirzepatide, including representations about the compounder and FDA evaluation. The letter concerns those GLP-1 products; it is not a finding that Strut’s sermorelin is contaminated or ineffective.

This is relevant company context when evaluating how a provider communicates about compounded drugs. The FDA letter describes FDA’s concerns at that time; we have not established a subsequent resolution.

Who may want to compare it

Strut may be worth a closer look if you want to discuss both formats and value published consultation and shipping inclusions. It is not a guaranteed fit for someone who wants a one-time order or a final quote before clinical review.

For readers considering injections only, compare the complete Strut quote with CoreAge Rx’s starting $99 monthly offer. Ask both providers the same questions so the comparison is about your actual plan.

Common questions

What is the price difference between formats?

Strut advertises $119 monthly for the injection and $99 for a 30-day lozenge supply. Its page says final pricing is determined after consultation.

Are the two formats equivalent?

The same ingredient does not establish equal absorption or clinical effects. Ask the clinician for formulation-specific evidence.

Are visits and shipping included?

Strut’s pricing section says physician consultations and shipping are included. Confirm what applies to your prescribed plan.

Explore Strut Health

Review the current offer, ask the unanswered questions, and let a clinician assess whether treatment is appropriate.

Visit Strut Health

Reader-supported. We may earn a commission when you use our partner links. How we’re funded

Sources & further reading

Provider information checked October 7, 2026. Prices and terms can change.

  1. Strut Health website
  2. FDA: Understanding the risks of compounded drugs
  3. Endocrine Society: Hormones and Aging scientific statement
  4. FDA: February 2026 warning letter to Strut Health